In last trading session, Sensei Biotherapeutics Inc (NASDAQ:SNSE) saw 0.54 million shares changing hands with its beta currently measuring 0.25. Company’s recent per share price level of $0.29 trading at -$0.04 or -11.25% at ring of the bell on the day assigns it a market valuation of $7.28M. That closing price of SNSE’s stock is at a discount of -568.97% from its 52-week high price of $1.94 and is indicating a premium of 13.79% from its 52-week low price of $0.25. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 16.32 million shares which gives us an average trading volume of 2.97 million if we extend that period to 3-months.
For Sensei Biotherapeutics Inc (SNSE), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.26 in the current quarter.
Sensei Biotherapeutics Inc (NASDAQ:SNSE) trade information
Upright in the red during last session for losing -11.25%, in the last five days SNSE remained trading in the red while hitting it’s week-highest on Monday, 03/31/25 when the stock touched $0.29 price level, adding 41.98% to its value on the day. Sensei Biotherapeutics Inc’s shares saw a change of -41.09% in year-to-date performance and have moved -43.20% in past 5-day. Sensei Biotherapeutics Inc (NASDAQ:SNSE) showed a performance of -35.79% in past 30-days. Number of shares sold short was 0.12 million shares which calculate 1.42 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 5.5 to the stock, which implies a rise of 94.73% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -1624.14% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1624.14% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -11.38% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 43.33% while estimates for its earnings growth in next 5 years are of 12.82%.
Sensei Biotherapeutics Inc (NASDAQ:SNSE)’s Major holders
Insiders are in possession of 34.14% of company’s total shares while institution are holding 9.35 percent of that, with stock having share float percentage of 14.20%. Investors also watch the number of corporate investors in a company very closely, which is 9.35% institutions for Sensei Biotherapeutics Inc that are currently holding shares of the company. IKARIAN CAPITAL, LLC is the top institutional holder at SNSE for having 0.65 million shares of worth $0.4 million. And as of 2024-06-30, it was holding 2.5949 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 0.62 million shares on 2024-06-30. The number of shares represents firm’s hold over 2.4702 of outstanding shares, having a total worth of $0.38 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 485.96 shares of worth $0.14 million or 1.93% of the total outstanding shares. The later fund manager was in possession of 99.62 shares on Dec 31, 2024 , making its stake of worth around $28759.0 in the company or a holder of 0.40% of company’s stock.
